Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

702
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
702
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Overview of Exosomes01:36

Overview of Exosomes

2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Cancer Vaccines01:30

Cancer Vaccines

539
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
539

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phytosulfokine peptide regulates growth-immunity tradeoff through CAMTA3-mediated transcriptional signaling in Arabidopsis.

Plant communications·2026
Same author

Metagenomic analysis of human feces reveals gut microbiome role in colorectal cancer.

Frontiers in cellular and infection microbiology·2026
Same author

Chikungunya virus nsP2: Insights into viral replication, pathogenesis, and therapeutic targeting.

Virulence·2026
Same author

Prevalence and clinical implications of Aspergillus infection among tuberculosis patients in Peru.

The Journal of infection·2026
Same author

Early mortality of surgical treatments of necrotizing enterocolitis: experience of a tertiary neonatal intensive care unit (NICU) in Southwest China: a retrospective cohort study.

Translational pediatrics·2026
Same author

Spin-selective high-numerical-aperture edge detection via detuned quasi-BIC and generalized Kerker effect.

Optics letters·2026

Related Experiment Video

Updated: Sep 30, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

904

Engineered extracellular vesicles: potentials in cancer combination therapy.

Jiangbin Chen1, Qi Tan1, Zimo Yang1

  • 1Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases of Health Ministry, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, Hubei, People's Republic of China.

Journal of Nanobiotechnology
|March 16, 2022
PubMed
Summary

Engineered extracellular vesicles (EVs) offer a promising platform for cancer therapy. This review details how modified EVs facilitate combination treatments, enhancing efficacy against complex cancers.

Keywords:
Cancer therapyCombinational therapyEngineered EVsExtracellular vesicles (EVs)

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.4K

Related Experiment Videos

Last Updated: Sep 30, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

904
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.7K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.4K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Extracellular vesicles (EVs) are natural nanocarriers with inherent biocompatibility and immune compatibility.
  • Their cargo delivery capability makes them attractive for drug delivery, particularly in cancer therapy.
  • Engineered EVs offer enhanced performance through various modification strategies.

Purpose of the Study:

  • To review current strategies for engineered EVs in cancer combination therapy.
  • To highlight the mechanisms and examples of engineered EV-mediated combination treatments.
  • To provide future directions for designing effective combination cancer therapies using engineered EVs.

Main Methods:

  • Review of literature on engineered extracellular vesicles for cancer therapy.
  • Analysis of modification methods for enhancing EV performance.
  • Summarization of combination therapy approaches utilizing engineered EVs.

Main Results:

  • Engineered EVs are increasingly used for combination cancer therapy, moving beyond monotherapy.
  • The plasticity and load capacity of engineered EVs enable diverse therapeutic combinations.
  • Various schemes demonstrate the potential of engineered EVs to overcome cancer heterogeneity and the tumor microenvironment.

Conclusions:

  • Engineered EVs represent a versatile platform for advanced cancer combination therapies.
  • Further development of engineered EVs can lead to more effective and personalized cancer treatment plans.
  • This review provides a framework for future research and clinical applications of engineered EVs in oncology.